Graphico

Graphico R&D / Revenue

Delisted

The R&D to Revenue Ratio of Graphico (4930.T) as of Nov 14, 2026 is 1.13 %. In the previous year, R&D to Revenue Ratio was 0.98 % — a change of 15.62% (higher).

R&D / Revenue

1.13 %

YoY

15.62%

Last updated:

R&D to Revenue Ratio of Graphico is 2023 1.13 % . R&D to Revenue Ratio of Graphico was 2022 0.98 % . It decreases by 15.62% higher compared to the previous year.

The Graphico R&D / Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D / Revenue
Date
R&D / Revenue
Jan 1, 2014
1.57 JPY
Jan 1, 2015
1.80 JPY
Jan 1, 2018
1.02 JPY
Jan 1, 2019
1.12 JPY
Jan 1, 2020
1.17 JPY
Jan 1, 2021
0.88 JPY
Jan 1, 2022
0.98 JPY
Jan 1, 2023
1.13 JPY
The Graphico R&D / Revenue history
YEARR&D / RevenueYoY
1.13 %+15.62%
0.98 %+11.48%
0.88 %-24.58%
1.17 %+4.42%
1.12 %+9.99%
1.02 %-43.69%
1.80 %+14.64%
1.57 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Graphico Stock analysis

What does Graphico do? Graphico Inc. generates revenue through the sale of health foods, cosmetics, ethical drugs, over-the-counter drugs, and household products via drug stores, general merchandise stores, home centers, variety stores, and mail-order channels. The company outsources manufacturing and logistics while focusing on product planning, development, marketing, and sales. Its main product categories include healthcare centered on health foods, beauty care centered on cosmetics, and ethical and over-the-counter drugs. Overseas sales are handled through country-specific distributors. The company targets consumers seeking health and beauty solutions through established retail channels and direct mail-order services. Product planning and development are central to its strategy, with a focus on health foods, cosmetics, and pharmaceuticals. The firm operates as a fabless business model, relying on external partners for manufacturing and logistics to maintain agility in product innovation. Graphico Inc. serves multiple segments including health-conscious women, beauty care consumers, and individuals seeking over-the-counter medications. Sales channels include drug stores, GMS, home centers, variety stores, and mail-order systems. The company's overseas presence is supported by distributors in each country, enabling global market access without direct operational infrastructure. Graphico is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Graphico stock

R&D to Revenue Ratio of Graphico is 1.13 % in 2023.

R&D to Revenue Ratio of Graphico changed from 0.98 % to 1.13 %, representing a 15.62% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D to Revenue Ratio Graphico since 2006 – with annual values, charts, and detailed analysis.

The R&D to Revenue ratio shows what percentage of revenue a company invests in research and development. Higher ratios indicate stronger focus on innovation.

A 'good' varies by industry and company stage. On Eulerpool, you can compare R&D to Revenue Ratio's Graphico with sector peers and the industry average to assess whether it is attractive.

To evaluate R&D to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for R&D to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Graphico

All Key Metrics — Graphico